RemeGen Co. Ltd. Class H (HK:9995) has released an update.
RemeGen Co., Ltd. has announced a board meeting scheduled for October 29, 2024, to review and approve the company’s unaudited third-quarter results. Investors are keenly watching as the company prepares to disclose its financial performance for the nine months ending September 30, 2024. This announcement is significant for stakeholders eager to assess the company’s growth and profitability in the competitive biotech sector.
For further insights into HK:9995 stock, check out TipRanks’ Stock Analysis page.